Decheng Capital China Life Sciences USD Fund III, L.P. → BeyondSpring Inc. BYSI

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 16/100

Passive Schedule 13G filer baseline
Elevated short days-to-cover (35.8 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

4 filings by this filer

3 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 35.77

2,353,319 shares short · -3.7% vs prior

Other Filings by Decheng Capital China Life Sciences USD Fund III, L.P.

Filed	Form	Issuer	Stake	Shares
2022-09-27	SC	ALPINE IMMUNE SCIENCES, INC.	—	—	view →
2021-09-21	SC	ALPINE IMMUNE SCIENCES, INC.	—	—	view →
2020-08-03	SC	ALPINE IMMUNE SCIENCES, INC.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →